<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suppression of osteomyelitis or prosthetic joint infection in adults: Oral antibiotic regimens*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suppression of osteomyelitis or prosthetic joint infection in adults: Oral antibiotic regimens*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suppression of osteomyelitis or prosthetic joint infection in adults: Oral antibiotic regimens*</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1">Infectious agent</td> <td class="subtitle1">Antibiotic regimen<sup>¶</sup></td> <td class="subtitle1">Dosing</td> </tr> <tr> <td class="divider_bottom" rowspan="5"><strong>Staphylococci, methicillin susceptible</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1">Cefadroxil</td> <td>500 to 1000 mg twice daily</td> </tr> <tr> <td class="indent1">Cephalexin</td> <td>500 mg 3 or 4 times daily, or 1000 mg 2 or 3 times daily</td> </tr> <tr> <td class="indent1">Dicloxacillin</td> <td>500 mg 3 or 4 times daily </td> </tr> <tr class="divider_bottom"> <td class="indent1">Flucloxacillin</td> <td>500 mg 3 or 4 times daily</td> </tr> <tr> <td class="divider_bottom" rowspan="5"><strong>Staphylococci, methicillin resistant</strong><sup>Δ</sup></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1">Trimethoprim-sulfamethoxazole</td> <td>1 double-strength tablet twice daily</td> </tr> <tr> <td class="indent1">Doxycycline</td> <td>100 mg twice daily</td> </tr> <tr> <td class="indent1">Minocycline</td> <td>100 mg twice daily</td> </tr> <tr class="divider_bottom"> <td class="indent1">Clindamycin</td> <td>600 mg 3 times daily</td> </tr> <tr> <td class="divider_bottom" rowspan="4"><strong>Gram-negative organisms</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1">Trimethoprim-sulfamethoxazole</td> <td>1 double-strength tablet twice daily</td> </tr> <tr> <td class="indent1">Ciprofloxacin<sup>◊</sup></td> <td>500 mg twice daily</td> </tr> <tr class="divider_bottom"> <td class="indent1">Levofloxacin<sup>◊</sup></td> <td>500 mg once daily</td> </tr> <tr> <td class="divider_bottom" rowspan="3"><strong>Penicillin-sensitive streptococci and enterococci</strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1">Amoxicillin</td> <td>500 mg 2 to 3 times daily</td> </tr> <tr class="divider_bottom"> <td class="indent1">Penicillin V K</td> <td>500 mg 2 to 4 times daily</td> </tr> <tr> <td rowspan="3"><strong><em>Cutibacterium</em> (formerly <em>Propionibacterium</em>) <em>acnes</em></strong></td> <td colspan="2"><strong>One of the following:</strong></td> </tr> <tr> <td class="indent1">Amoxicillin</td> <td>500 mg 2 to 3 times daily</td> </tr> <tr> <td class="indent1">Penicillin V K</td> <td>500 mg 2 to 3 times daily</td> </tr> </tbody></table></div><div class="graphic_lgnd">The doses recommended above are intended for adults with normal renal function; the doses of some of these agents must be adjusted in patients with renal insufficiency. Refer to the Lexicomp drug-specific monographs for renal dose adjustments.</div><div class="graphic_footnotes">PJI: Prosthetic joint infection.<br/>	

	* Initial treatment of PJI consists of definitive antibiotic therapy (refer to the separate UpToDate table); suppressive therapy is warranted only for individuals with retained hardware and/or necrotic bone not amenable to complete debridement. The optimal duration of oral suppressive antibiotic therapy is uncertain. Refer to the UpToDate topic on the treatment of PJI for further discussion.<br/>	

	¶ The choice of antibiotic regimen should be based on susceptibility, as well as patient drug allergies, intolerances, and potential drug-drug interactions or contraindications to a specific agent.<br/>	

	Δ The agents listed for methicillin-resistant staphylococci may be used for suppression of methicillin-susceptible staphylococci in patients with beta-lactam allergy or intolerance, provided the organism is susceptible.<br/>
<span class="lozenge">◊</span> Ciprofloxacin and levofloxacin have activity against <em>Pseudomonas aeruginosa</em>.</div><div class="graphic_reference">Data from:

	<ol>
<li>Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013; 56:e1.</li>
<li>Berbari EF, Kanj SS, Kowalski TJ, et al. 2015 Infectious Diseases Society of America (IDSA) clinical practice guidelines for the diagnosis and treatment of native vertebral osteomyelitis in adults. Clin Infect Dis 2015; 61:e26.</li>
</ol></div><div id="graphicVersion">Graphic 119913 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
